GO-BP
|
axonogenesis
|
46
|
< 0.001
|
GO-BP
|
axon development
|
48
|
< 0.001
|
GO-BP
|
Ras protein signal transduction
|
45
|
< 0.001
|
GO-BP
|
eye development
|
37
|
< 0.001
|
GO-BP
|
mesenchyme development
|
30
|
< 0.001
|
GO-CC
|
cell leading edge
|
37
|
< 0.001
|
GO-CC
|
actin cytoskeleton
|
40
|
0.002
|
GO-CC
|
cortical cytoskeleton
|
15
|
0.002
|
GO-CC
|
lamellipodium
|
21
|
0.002
|
GO-CC
|
cell cortex
|
28
|
0.002
|
GO-MF
|
transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding
|
41
|
< 0.001
|
GO-MF
|
transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding
|
38
|
< 0.001
|
GO-MF
|
transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding
|
28
|
< 0.001
|
GO-MF
|
proximal promoter sequence-specific DNA binding
|
37
|
< 0.001
|
GO-MF
|
nucleoside-triphosphatase regulator activity
|
31
|
< 0.001
|
KEGG
|
Axon guidance
|
21
|
< 0.001
|
KEGG
|
Melanogenesis
|
15
|
< 0.001
|
KEGG
|
Longevity regulating pathway - multiple species
|
11
|
< 0.001
|
KEGG
|
Parathyroid hormone synthesis, secretion and action
|
14
|
< 0.001
|
KEGG
|
Glutamatergic synapse
|
14
|
< 0.001
|